Topical Therapy for Prevention of Infections in Preterm Infants
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00162747|
Recruitment Status : Completed
First Posted : September 13, 2005
Last Update Posted : September 13, 2005
|Condition or disease||Intervention/treatment||Phase|
|Skin Diseases||Drug: Aquaphor Drug: Sunflower Seed Oil||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||600 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Topical Emollient Therapy for Prevention of Infections in Preterm Infants|
|Study Start Date :||December 2001|
|Estimated Study Completion Date :||June 2005|
- Three weeks after application of the intervention, blood will be drawn from those enrolled in the control group.
- Atleast four additional times over the first four weeks of the child's life, the skin will be studied by lightly rubbing the skin with a cotton swab to detect germs on the skin and observing and recording the condition of the baby's skin.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00162747
|Dhaka Shishu Hospital|
|Principal Investigator:||Gary L Darmstadt, MD||Johns Hopkins Bloomberg School of Public Health|